Skip to main content

Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine?

Publication ,  Journal Article
Kim, RJ; Manning, WJ
Published in: Circulation
June 1, 2004

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

June 1, 2004

Volume

109

Issue

21

Start / End Page

2476 / 2479

Location

United States

Related Subject Headings

  • Tomography, Emission-Computed, Single-Photon
  • Sensitivity and Specificity
  • ROC Curve
  • Myocytes, Cardiac
  • Myocardium
  • Myocardial Revascularization
  • Myocardial Infarction
  • Models, Animal
  • Magnetic Resonance Imaging, Cine
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kim, R. J., & Manning, W. J. (2004). Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine? Circulation, 109(21), 2476–2479. https://doi.org/10.1161/01.CIR.0000130730.63776.69
Kim, Raymond J., and Warren J. Manning. “Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine?Circulation 109, no. 21 (June 1, 2004): 2476–79. https://doi.org/10.1161/01.CIR.0000130730.63776.69.
Kim, Raymond J., and Warren J. Manning. “Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine?Circulation, vol. 109, no. 21, June 2004, pp. 2476–79. Pubmed, doi:10.1161/01.CIR.0000130730.63776.69.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

June 1, 2004

Volume

109

Issue

21

Start / End Page

2476 / 2479

Location

United States

Related Subject Headings

  • Tomography, Emission-Computed, Single-Photon
  • Sensitivity and Specificity
  • ROC Curve
  • Myocytes, Cardiac
  • Myocardium
  • Myocardial Revascularization
  • Myocardial Infarction
  • Models, Animal
  • Magnetic Resonance Imaging, Cine
  • Humans